Early adoption of anti–SARS-CoV-2 pharmacotherapies among veterans with mild to moderate COVID-19
About The Study: In this study of more than 111,000 veterans who tested positive for SARS-CoV-2 during January and February ...
Tag: antiSARSCoV2
Administration of anti–SARS-CoV-2 monoclonal antibodies after FDA deauthorization
About The Study: Hospitals and health systems administered more than 158,000 anti–SARS-CoV-2 monoclonal antibodies (mAbs) doses in early 2022 despite Food ...
UTMB study shows common antibody therapy has anti-SARS-CoV-2 Antibodies
GALVESTON, Texas – Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS--COV-2 ...
Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
In this new article publication from Acta Pharmaceutica Sinica B, authors Zhen Qin, Bin Dong, Renbing Wang and colleagues from ...
-
The “Stonehenge calendar” shown to be a modern construct
-
Spotted lanternfly spreads by hitching a ride with humans
-
Light meets deep learning: computing fast enough for next-gen AI
-
Remains of a modern glacier found near mars’ equator implies water ice possibly present at low latitudes on Mars even today
-
Null results research now published by major behavioral medicine journal
-
“Glassiness” and “blurriness” might explain the behavior of high-entropy superconductors